The circular RNA circSLC7A11 functions as a mir-330-3p sponge to accelerate hepatocellular carcinoma progression by regulating cyclin-dependent kinase 1 expression
Related Experiment Video
Updated: Oct 11, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Yu Huang1,2,3,4,5,6, Wenhao Ge1,2,3,4,5,6, Yuan Ding1,2,3,4,5,6
1Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
Background:
Circular RNAs (circRNAs), which are endogenous non-coding RNAs, are associated with various biological processes including development, homeostatic maintenance, and pathological responses. Accumulating evidence has implicated non-coding RNAs in cancer progression, and the role of circRNAs in particular has drawn wide attention. However, circRNA expression patterns and functions in hepatocellular carcinoma (HCC) remain poorly understood.
Methods:
CircRNA sequencing was performed to screen differentially expressed circRNAs in HCC. Northern blotting, quantitative real-time polymerase chain reaction, nucleocytoplasmic fractionation, and fluorescence in situ hybridization analyses were conducted to evaluate the expression and localization of circSLC7A11 in HCC tissues and cells. CircSLC7A11 expression levels were modified in cultured HCC cell lines to explore the association between the expression of circSLC7A11 and the malignant behavior of these cells using several cell-based assays. The modified cells were implanted into immunocompetent nude mice to assess tumor growth and metastasis in vivo. We applied bioinformatics methods, RNA pulldown, RNA immunoprecipitation, and luciferase reporter assays to explore the mechanisms of circSLC7A11 in HCC.
Results:
CircSLC7A11 (hsa_circ_0070975) was conserved and dramatically overexpressed in HCC tissues and cells. HCC patients showing high circSLC7A11 expression had worse prognoses. Our in vitro and in vivo experiments showed that circSLC7A11 markedly accelerated HCC progression and metastasis through the circSLC7A11/miR-330-3p/CDK1 axis.
Conclusions:
The acceleration of HCC progression and metastasis by circSLC7A11 through the circSLC7A11/miR-330-3p/CDK1 axis suggests that circSLC7A11 is a potential novel diagnostic and therapeutic target for HCC treatment.
Insights
Circular RNAs (circRNAs) accelerate hepatocellular carcinoma (HCC) progression and metastasis. CircSLC7A11 promotes HCC via the circSLC7A11/miR-330-3p/CDK1 axis, indicating its potential as a diagnostic and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are endogenous non-coding RNAs involved in biological processes.
- Non-coding RNAs, particularly circRNAs, are increasingly implicated in cancer progression.
- The specific roles of circRNAs in hepatocellular carcinoma (HCC) require further elucidation.
Purpose of the Study:
- To investigate the expression patterns and functions of circRNAs in HCC.
- To identify specific circRNAs involved in HCC progression and metastasis.
- To explore the potential of circRNAs as diagnostic and therapeutic targets for HCC.
Main Methods:
- CircRNA sequencing to identify differentially expressed circRNAs in HCC.
- Quantitative real-time PCR, Northern blotting, and in situ hybridization to analyze circSLC7A11 expression and localization.
- In vitro cell-based assays and in vivo mouse models to assess the impact of circSLC7A11 on HCC malignancy and metastasis.
- Bioinformatics, RNA pulldown, RNA immunoprecipitation, and luciferase reporter assays to elucidate the molecular mechanisms of circSLC7A11.
Main Results:
- CircSLC7A11 (hsa_circ_0070975) was significantly overexpressed in HCC tissues and cells and associated with poor prognosis.
- In vitro and in vivo studies demonstrated that circSLC7A11 accelerates HCC progression and metastasis.
- The mechanism involves the circSLC7A11/miR-330-3p/CDK1 axis, highlighting a novel regulatory pathway.
Conclusions:
- CircSLC7A11 plays a critical role in promoting HCC progression and metastasis.
- The circSLC7A11/miR-330-3p/CDK1 axis represents a key pathway in HCC development.
- CircSLC7A11 emerges as a promising novel diagnostic and therapeutic target for HCC treatment.
Related Concept Videos
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
Positive Regulator Molecules
The Ras Gene
Ras is a...
Negative Regulator Molecules

